Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma

Human Pathology

Volumn 31, Issue 9, 2000, Pages 1088-1095

  Pirinen, Risto ^a,b,c,d   Hirvikoski, Pasi ^a,b,c,d   Böhm, Jan ^a,b,c,d   Kellokoski, Jari ^a,b,c,d   Moisio, Kaisa ^a,b,c,d   Virén, Markku ^a,b,c,d   Johansson, Risto ^a,b,c,d   Hollmén, Sinikka ^a,b,c,d   Kosma, Veli Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

CD44; Immunohistochemistry; In situ hybridization; Lung carcinoma; RT PCR

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN;

ADULT; AGED; ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; OUTCOMES RESEARCH; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0033804508     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2000.16277     Document Type: Article

References (35)

1. CD44: The hyaluronan receptor
2. CD44: Structure, function, and association with the malignant process
3. CD44 and the adhesion of neoplastic cells
4. Decreased expression of CD44 in metastatic prostate cancer
5. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma
6. Normal human tissues, in addition to some tumors express multiple different CD44 isoforms
7. Preferential histiotypic expression of CD44-isoforms in human lung cancer
8. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer
9. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor
10. Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant transformation of turnouts of squamocellular origin
11. CD44V6 expression in human colorectal carcinoma
12. Nonradioactive in situ hybridization for detection of mRNAs encoding for peroxisomal proteins: Heterogeneous hepatic lobular distribution after treatment with a single dose of bezafibrate
13. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
14. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma
15. CD44 expression in benign, premalignant and malignant ovarian neoplasms: Relation to tumour development and progression
16. Expression of CD44 in human lung tumors
17. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas
18. Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung
19. Molecular studies into the role of CD44 variants in metastasis in gastric cancer
20. Expression of human CD44v6 in non-small-cell lung cancer
21. CD44 and its v6 spliced variant in lung tumors: A role in histogenesis?
22. Expression of the cell adhesion molecule CD44 in human lung tumors and cell lines
23. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer
24. Altered expression of CD44 isoforms in squamous cell carcinomas and cell lines derived from them
25. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of non-small cell lung carcinoma with intrapulmonary metastases
26. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer
27. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas
28. Downregulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastases
29. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: No evidence for altered CD44 splicing in metastasis
30. Expression of CD44 splicing isoforms in lung cancers: Dominant expression of CD44v8-10 in non-small cell lung carcinomas
31. CD44 is an independent prognostic factor in early-stage cervical cancer
32. CD44 expression in normal, hyperplastic, and malignant endometrium
33. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products
34. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration